MIRA INFORM REPORT

 

 

Report Date :

22.11.2008

 

IDENTIFICATION DETAILS

 

Name :

AMRI INDIA PRIVATE LIMITED

 

 

Registered Office :

Plot No.G-39/5, MIDC Industrial Area, Waluj, Aurangabad - 431133, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007 – (FINEKEM LABORATORIES PRIVATE LIMITED)

 

 

Date of Incorporation :

07.04.2007

 

 

Com. Reg. No.:

169746

 

 

CIN No.:

[Company Identification No.]

U74999MH2007FT169746

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA30116C

 

 

PAN No.:

[Permanent Account No.]

AAGCA2555H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of API Generic

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Finekem has been merged with AMRI India Private Limited w.e.f. April 2008 as confirmed by the management. However, the management declined to part with latest financials. The financials mentions in the report pertains to Finekem Laboratories Prior to merger. Trade relations are fair. No further details or payment records could be made available.

 

The company can be considered for any business dealings on safe and secured terms, initially.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Ms. Mamta Saxena

Designation :

Accountant

Date :

12.11.2008

 

 

LOCATIONS

 

Registered Office :

Plot No.G-39/5, MIDC Industrial Area, Waluj, Aurangabad - 431133, Maharashtra, India

Tel. No.:

91-240-2561229/ 2552028

Fax No.:

91-240-2560213/ 2359233

E-Mail :

finekemlab@vsnl.net

rakesh.doshi@amriglohali.com

mamta.saxena@amriglohali.com

Website :

http://www.amriglohali.com

 

 

Corporate Office :

12th Floor, Corporate Part II, V. N. Purav Marg,  (Sion Trombay Road), Chembur Mumbai – 400071, Maharashtra, India  

Tel. No.:

91-22-67745000/02

Fax No.:

91-22-67745010

Locations :

Rented

 

 

Factory :

Express Tower, 23rd Floor, Nariman Point, Mumbai – 400021, Maharashtra, India

Email :

rpavrey@vsnl.com

 

 

DIRECTORS

 

Name :

Mr. Rakesh Arun Doshi

Designation :

Director

Address :

8 Sri Nilayam, 182 Garodia Nagar, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

Date of Birth/Age :

04.02.1964

Date of Appointment :

21.06.2005

Email :

rdoshi@bom3.vsnl.net.in

 

 

Name :

Mrs. Usha Rakesh Doshi

Designation :

Director

Address :

8 Sri Nilayam, 182 Garodia Nagar, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

Date of Birth/Age :

31.08.1963

Date of Appointment :

05.02.2006

 

 

Name :

Mr. Michael Paul Williams

Designation :

Director

Address :

14, Lake Ridge Dr. Mechanicville, New York – 12118

Date of Birth/Age :

10.04.1958

Date of Appointment :

17.01.2008

Email :

Michael.williams@amriglobal.com

 

 

Name :

Mr. Prasad Raje

Designation :

Director

Date of Birth/Age :

48 years

 

 

Name :

Mr. Vinod Goswami

Designation :

Director

Address :

A-17, Old Sindhi Colony, Sahijpur Bogha, Ahmedabad – 382345, Gujarat, India

Date of Birth/Age :

10.10.1978

Date of Appointment :

09.04.2007

Email :

g.vinod@albmolecular.com

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 20.09.2007) (FINEKEM LABORATORIES PRIVATE LIMITED)

 

Names of Shareholders

 

No. of Shares

 

 

 

Rakesh Arun Doshi

 

318500

Usha Rakesh Doshi

 

20000

 

 

 

Total

 

338500

 

 (As on 30.09.2007)

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of API Generic

 

 

Exports :

 

Countries :

  • Latin America
  • Pakistan

 

 

Terms :

 

Selling :

L/C, and Credit (30 days)

 

 

Purchasing :

Credit (30 days)

 


 

GENERAL INFORMATION

 

Customers :

  • End Users
  • Manufacturing Unit

 

 

No. of Employees :

32

 

 

Bankers :

  • Bank of India

Ghatkopar (West) Branch, Mumbai, Maharashtra, India

 

 

Facilities :

Secured Loans

313.03.2007

(Rs. In Millions)

 

 

Bank of India 0006 C/C

5.087

Bank of India 0013 T/L

15.918

Bank of India 0017 T/L

1.866

Total

22.871

 

Unsecured Loans

313.03.2007

(Rs. In Millions)

 

 

From Directors

1.865

Revie Impex

1.700

Total

3.565

 

Banking Relations :

-

 

 

Auditors :

 

Name :

Gunvant Patil and Associates

Chartered Accountant

Address :

1st Floor, Satya Dham Complex, Jalna Road, Aurangabad – 431002, Maharashtra, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.10/- each

Rs.5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

338500

Equity Shares

Rs.10/- each

Rs.3.385 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

(FINEKEM LABORATORIES PRIVATE LIMITED)

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

3.385

3.385

0.100

2] Share Application Money

4.850

2.700

5.684

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

(8.168)

(1.792)

(1.378)

NETWORTH

0.067

4.293

4.406

LOAN FUNDS

 

 

 

1] Secured Loans

22.871

15.947

5.444

2] Unsecured Loans

3.565

2.310

0.000

TOTAL BORROWING

26.436

18.257

5.444

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

26.503

22.550

9.850

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

21.223

20.342

7.998

Capital work-in-progress

0.000

0.000

0.131

 

 

 

 

INVESTMENT

0.448

0.285

0.242

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

6.632

3.229

2.756

 

Sundry Debtors

1.935

0.104

0.004

 

Cash & Bank Balances

0.005

0.042

0.021

 

Other Current Assets

0.000

0.000

0.386

 

Loans & Advances

2.339

1.523

0.000

Total Current Assets

10.911

4.898

3.167

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

7.178

4.024

1.688

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

7.178

4.024

1.688

Net Current Assets

3.733

0.874

1.479

 

 

 

 

MISCELLANEOUS EXPENSES

0.042

0.042

0.000

Goodwill

1.057

1.007

0.000

 

 

 

 

TOTAL

26.503

22.550

9.850

 


 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

Debt Equity Ratio

(Total Liability/Networth)

 

501.70

5.19

1.62

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.52

1.22

1.88

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade Reference:

 

  • Intas Pharmaceuticals
  • Sun Pharma
  • Nicholas Piramal

 

 

Fixed Assets:

 

  • Land
  • Building
  • Plant and Machinery
  • Electrification
  • Mobile Hand Set
  • Office Equipment
  • Computer
  • Lab Equipment

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.50.03.

UK Pound

1

Rs.74.42

Euro

1

Rs.62.71

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions